ALLMedicine™ Acinetobacter Center
Research & Reviews 2,169 results
American Journal of Infection Control; Perez LRR, Carniel E et. al.
Jul 30th, 2021 - To determine the trends of antimicrobial resistance for Acinetobacter baumannii complex isolates recovered from inpatients over a 4-year follow-up survey. A total of 659 Acinetobacter baumannii complex isolates were recovered from hospitalized pat...
BMC Infectious Diseases; Babaei S, Haeili M
Jul 29th, 2021 - The current emergence of multi-drug resistance among nosocomial pathogens has led to increased use of last-resort agents including Tigecycline (TGC). Availability of reliable methods for testing TGC susceptibility is crucial to accurately predict ...
Infection and Immunity; Nielsen TB, Yan J et. al.
Jul 27th, 2021 - Background: Extremely drug-resistant (XDR) Acinetobacter baumannii is a notorious and frequently encountered pathogen demanding novel therapeutic interventions. An initial monoclonal antibody (MAb), C8, raised against A. baumannii capsule proved a...
Infection Control and Hospital Epidemiology; Cadnum JL, Pearlmutter BS et. al.
Jul 24th, 2021 - To investigate the frequency of environmental contamination in hospital areas outside patient rooms and in outpatient healthcare facilities. Culture survey. This study was conducted across 4 hospitals, 4 outpatient clinics, and 1 surgery center. W...
International Journal of Antimicrobial Agents; Chen T, Fu Y et. al.
Jul 24th, 2021 - Fifty-four unique clinical A. baumannii strains isolated from cerebrospinal fluid (CSF) together with 21 bloodstream isolates collected from 5 tertiary hospitals in East China between April 2013 and November 2016 were studied for susceptibility pa...
Guidelines 3 results
Antimicrobial Agents and Chemotherapy; Pogue JM, Jones RN et. al.
Nov 27th, 2019 - The polymyxins are important agents for carbapenem-resistant Gram-negative bacilli. The United States Committee on Antimicrobial Susceptibility Testing breakpoint recommendations for colistin and polymyxin B are that isolates of Pseudomonas aerugi...
Intensive Care Medicine; Garnacho-Montero J, Dimopoulos G et. al.
Oct 7th, 2015 - Acinetobacter baumannii constitutes a dreadful problem in many ICUs worldwide. The very limited therapeutic options available for these organisms are a matter of great concern. No specific guidelines exist addressing the prevention and management ...
American Journal of Infection Control; Rebmann T, Greene LR
Sep 28th, 2010 - The Association for Professionals in Infection Control and Epidemiology (APIC) began publishing their series of Elimination Guides in 2007. Since then, 9 Elimination Guides have been developed that cover a range of important infection prevention i...
Drugs 272 results see all →
Clinicaltrials.gov 22 results
Oct 30th, 2018 - Nosocomial Central Nervous System infections are difficult to treat and an early appropriate therapy can improve prognosis. The two main reasons for treatments failure are the difficulty to reach high concentrations of antibiotics (ATB) in CNS bec...
Aug 2nd, 2018 - This study will evaluate the neonates with VAP due to PDR-Acinetobacter baumannii who receive aerosolized plus intravenous colistin compare with intravenous colistin as adjunctive therapy. The efficacy and safety after study will be evaluated.
Jun 14th, 2018 - Medical records will be reviewed and information collected to assess the clinical outcomes of patients with Acinetobacter bloodstream infection and to further assess the predictors of mortality in this patient population.
Jun 12th, 2018 - The elucidation of potential risk factors for resistant strains of Acinetobacter is therefore an important task, and the use of alternative antibiotics should be considered in ICUs where these strains are endemic.he following information will be c...
Jun 12th, 2018 - Medical records will be reviewed and information collected from charts to assess for independent predictors of in-hospital mortality (up to 28 days) in patients with Acinetobacter bloodstream infection. 24 sites will participate and all informatio...
News 71 results
Nov 23rd, 2020 - Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. On July 1, 2020, when I began a rotation on the infectious disease consult service at the Veterans Administration Hospital in Atlanta, we had three patients with...
Summary Company Announcement Date: May 28, 2019 FDA Publish Date: May 28, 2019 Product Type: Drugs Reason for Announcement: Recall Reason Description Sterility Failure Company Name: Heritage Pharmaceuticals Inc. Brand Name: Brand Name(s) Heritage ...
Dec 12th, 2018 - DNA from an abundance of bacteria linked to healthcare-associated infections, including Staphylococcus, was found on stethoscopes carried by healthcare professionals in the ICU, and cleaning only led to a modest reduction, researchers found. On a ...
Nov 14th, 2018 - ORLANDO – More therapies are becoming available for children for the treatment of influenza and multidrug-resistant infections such as Enterobacteriaceae and Acinetobacter, John S. Bradley, MD, said at the annual meeting of the American Academy of.
Oct 8th, 2018 - SAN FRANCISCO — Five standout antibiotics were featured during a pipeline session here at IDWeek 2018. The application process was open to all companies and the agents selected had the most novel data and are likely to have to most impact, said Ce...